Literature DB >> 601431

A clinical and prospective chromosomal study of yttrium-90 synovectomy.

D V Doyle, J S Glass, P J Gow, M Daker, R Grahame.   

Abstract

Yttrium-90 synovectomy resulted in complete resolution of chronic knee synovitis in 40% of a group of 15 patients. These patients would have otherwise required surgical synovectomy. The number of chromosomal aberrations detected in 30 patients after yttrium-90 synovectomy showed a statistically significant increase over the pre-treatment analysis, and, following treatment, chromosomal damage was noted in nine patients who had no damage before treatment. The risk arising from this chromosomal damage is uncertain but, while the long-term implications of the chromosomal aberrations are investigated in those who have already been treated, this therapy should be reserved for the older patient.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 601431     DOI: 10.1093/rheumatology/16.4.217

Source DB:  PubMed          Journal:  Rheumatol Rehabil        ISSN: 0300-3396


  4 in total

1.  The effect of the beta-emitting yttrium-90 citrate on the dose-response of dicentric chromosomes in human lymphocytes: a basis for biological dosimetry after radiosynoviorthesis.

Authors:  E Schmid; H-J Selbach; M Voth; J Pinkert; F J Gildehaus; R Klett; M Haney
Journal:  Radiat Environ Biophys       Date:  2006-05-30       Impact factor: 1.925

2.  Comparison of two yttrium-90 regimens in inflammatory and osteoarthropathies.

Authors:  R Will; B Laing; J Edelman; F Lovegrove; I Surveyor
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

3.  Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy for chronic knee synovitis.

Authors:  E K O'Duffy; G P Clunie; D Lui; J C Edwards; P J Ell
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

4.  Synovectomy of the knee with 90Y.

Authors:  P F Spooren; J J Rasker; R P Arens
Journal:  Eur J Nucl Med       Date:  1985
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.